Every 8-K that Regional Health (RHE) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow RHE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RHE filings page.
Regional Health Properties, Inc. completed its previously announced merger with SunLink Health Systems, Inc., with SunLink merging into Regional and Regional surviving as the combined company. At the effective time, each five shares of SunLink common stock were converted into the right to receive 1.1330 shares of Regional common stock and one share of newly created Regional Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, with cash paid instead of fractional shares. The total aggregate merger consideration was approximately 1,595,400 shares of Regional common stock and approximately 1,408,120 shares of Regional Series D preferred stock.
The board of directors was expanded to seven members, combining three continuing Regional directors, two former SunLink directors, and two mutually designated directors, with Brent S. Morrison continuing as Chairman, President, and Chief Executive Officer. Regional also entered into an amended and restated employment agreement with Mr. Morrison and an employment agreement with Robert M. Thornton, Jr., including a restricted stock inducement award covering 100,000 shares of Regional common stock for Mr. Thornton as Executive Vice President – Corporate Strategy.
Regional Health Properties (RHE) filed an 8-K after convening a 29-Jul-25 special meeting of common shareholders focused on its pending merger with SunLink Health Systems. The sole agenda item—authority to adjourn the meeting to solicit additional votes for the merger and related share-issuance proposals—passed with 1,043,581 votes “for,” 298,162 “against,” and 13,382 abstentions (no broker non-votes), reflecting 77.2% support.
The meeting will reconvene at company headquarters on 4-Aug-25, 10:00 a.m. ET; the 20-Jun-25 record date and previously submitted proxies remain valid. Approval of the merger itself and regulatory clearances are still pending.
RHE reiterated risk factors covering integration, regulatory approvals, listing compliance, leverage and macro conditions. Its common and Series A preferred shares continue to trade OTCQB (symbols RHEP, RHEPA) following NYSE American delisting on 11-Jun-25. No earnings or operational metrics were disclosed.
Form 8-K (Item 8.01) filed 24 Jul 2025 by Regional Health Properties (RHE) merely announces the public posting of an investor presentation and a shareholder letter (Exhibits 99.1 & 99.2). Both documents relate to the pending all-stock merger with SunLink Health Systems; the joint proxy statement/prospectus (Form S-4, File No. 333-286975) was mailed on 30 Jun 2025 and a Schedule TO for a tender offer was filed on 18 Jul 2025.
Context & risks: The company reminds investors that its common and Series A preferred shares were delisted from NYSE American on 11 Jun 2025 and now trade on the OTCQB (tickers RHEP, RHEPA). No financial results or guidance are provided. Extensive forward-looking language restates integration, regulatory, liquidity and leverage risks that could derail or diminish anticipated merger synergies. Apart from furnishing additional disclosure materials, the filing makes no new commitments, and it expressly disclaims constituting an offer to sell securities.
Regional Health Properties (RHE) and SunLink Health Systems have amended their Merger Agreement, extending the termination deadline from June 30, 2025, to August 11, 2025, 5:00 PM ET. This extension comes as both companies acknowledge that required shareholder approvals have not been obtained and are unlikely to be secured by the original deadline.
Key developments include:
- NYSE American filed Form 25 on June 11, 2025, to delist Regional's common stock and Series A Preferred Stock
- Both securities now trade on OTCQB under symbols "RHEP" and "RHEPA"
- Regional will file an S-4 Registration Statement including a joint proxy statement/prospectus for the proposed merger
The merger remains subject to several risks, including integration challenges, potential revenue synergy shortfalls, regulatory approvals, and shareholder approvals. The company cautions investors about forward-looking statements and urges review of the forthcoming joint proxy statement/prospectus for complete merger details.